Month: July 2020

SATO Oyj, Johdon liiketoimet, 22.7.2020 klo 14.30IlmoitusvelvollinenNimi: Balder Finska Otas ABAsema: Lähipiiriin kuuluva henkilö(X) Oikeushenkilö(1):Liikkeeseenlaskijassa johtotehtävissä toimiva henkilöNimi: Selin, ErikAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: SATO OyjLEI: 7437009ELUGUOA45V564Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 7437009ELUGUOA45V564_20200722091217_11____________________________________________Liiketoimen päivämäärä: 2020-07-21Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009011688Liiketoimen luonne: HANKINTALiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 54 000 Yksikköhinta: 39,00 EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 54 000 Keskihinta: 39,00 EURLisätietoja:SATO OyjKatri Innanen, lakiasiainjohtaja, p. 0201 34 4014 ja 0400 678 898www.sato.fiSATO Oyj on yksi Suomen johtavista...

LOS ANGELES, July 22, 2020 (GLOBE NEWSWIRE) — Omni-lite Industries (TSXV: OML) (OTCQX: OLNCF) announces today that manufacturing at its California facility will be suspended for 2 weeks beginning July 22, 2020 and will reopen August 4, 2020 in accordance with CDC COVID-19 guidelines and putting highest priority on our employees safety. “We expect this to have minimal effect on Q3 Revenue performance as on hand finished goods inventory levels will support projected customer requirements,” said CEO Dave Robbins.       Omni-Lite’s East Coast Monzite manufacturing facility is fully staffed and operational.About Omni-Lite Industries Canada Inc.Omni-Lite Industries Canada Inc. is an innovative company that develops and manufactures mission critical, precision components utilized by Fortune 100 companies in the aerospace and defense industries.For...

U. S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million additional dosesAmericans to receive the vaccine for free consistent with U.S. government’s commitment for free access for COVID-19 vaccines Pfizer and BioNTech remain on track to begin an anticipated Phase 2b/3 safety and efficacy trial later this month, seek regulatory review as early as October 2020, and manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021NEW YORK and MAINZ, Germany, July 22, 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s Operation Warp...

US-Regierung hat eine initiale Bestellung über 100 Millionen Dosen für 1,95 Mrd. US-Dollar aufgegeben, und kann weitere 500 Millionen Dosen erwerbenAmerikanische Bevölkerung erhält den Impfstoff kostenlos, entsprechend der Zusage der US-Regierung, einen freien Zugang zu COVID-19-Impfstoffen zu bietenPfizer und BioNTech sind im Zeitplan, noch diesen Monat die erwartete Phase-2b/3-Sicherheits- und Wirksamkeitsstudie zu beginnen, bereits im Oktober 2020 das Zulassungsverfahren zu beantragen, sowie weltweit bis zu 100 Millionen Impfstoffdosen bis Ende 2020 sowie potenziell über 1,3 Milliarden Impfstoffdosen bis Ende 2021 herzustellenNEW YORK, USA und MAINZ, DEUTSCHLAND, July 22, 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX, „BioNTech”) gaben heute den Abschluss einer Vereinbarung mit dem US-amerikanischen...

PETAH TIKVA, Israel, July 22, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announces that Gilat received an extension for an 18-month managed service cellular backhaul project from a leading Mobile Network Operator (MNO) in Mexico.The leading MNO will provide 3G and 4G services over Gilat’s satellite backhaul to remote regions where terrestrial means such as fiber and microwave are not available. In addition, Gilat’s satellite platform will allow the mobile operator to use transportable VSATs, for disaster recovery, thus ensuring connectivity anywhere in Mexico at all times. The capacity increase of 40% will enable Gilat to provide a superior end-to-end solution for the operator to expand its service into remote...

Daniel M. Skovronsky, M.D., Ph.D. Elected to Myriad’s Board of Directors. Walter (Wally)Gilbert, Ph.D., announces upcoming retirement from the Board of DirectorsSALT LAKE CITY, July 22, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced the election of Daniel M. Skovronsky, M.D., Ph.D., age 47, to its Board of Directors, effective immediately, expanding the Board to ten members.  Additionally, Dr. Skovronsky was appointed to the Research and Product Innovation Committee of Myriad’s Board.Dr. Skovronsky serves as Chief Science Officer and President of Lilly Research Laboratories at Eli Lilly and Company.  He previously served as the Founder and Chief Executive Officer of Avid Radiopharmaceuticals, Inc. which used...

GOLETA, Calif., July 22, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced it will release financial results for the second quarter ended June 30, 2020, after market close on Wednesday, August 5, 2020.Management will host an investor conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on August 5, 2020, to discuss Resonant’s second quarter 2020 financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information:Conference Call and WebcastDate: Wednesday, August 5, 2020Time: 1:30 p.m. Pacific Daylight Time (4:30 p.m. Eastern Daylight Time)U.S. Dial-in: 1-877-423-9813International Dial-in: 1-201-689-8573Conference...

Bestyrelsen i Kapitalforeningen Accunia Invest har godkendt nedennævnte udbytter for andet kvartal af 2020.De optjente udbytter er vist i nedenstående tabel. Tallene er opgjort i kr. pr. investeringsbevis.Automatisk geninvestering – For automatisk geninvestering skal investor kontakte sin egen depotbank. Geninvesteringskurserne fastsættes og gennemføres til indre værdier per den 28. august 2020 fratrukket udbytte.Tidsplan27. august 2020 – Sidste dag for handel med beviser inkl. udbytte28. august 2020 – Udbyttet fragår, og investeringsbeviserne handles uden udbytte30. august 2020  – Udbyttet er til disposition på investors kontoKontaktperson(er):Direktør Caspar Møller, tlf. +45 3332 7070.Yderligere oplysninger om Kapitalforeningen Accunia Invest findes på www.accunia.com.